HomeNewsBusinessStocksBuy Escorts, Dishman Pharma, India Cements: Deshmukh
Trending Topics
Sensex Live
Pine Labs IPO Day 1
Groww IPO Day 3 GMP
Upcoming IPOs
Gold Rate

Buy Escorts, Dishman Pharma, India Cements: Deshmukh

Akshata Deshmukh of Networth Capital recommends buying India Cements for a target of Rs 59.50 and Dishman Pharmaceuticals & Chemicals for a target of Rs 96.

March 06, 2014 / 12:23 IST
Story continues below Advertisement
Remove Ad

In CNBC-TV18's popular show Bull's Eye, Akshata Deshmukh of Networth Capital shares her trading strategies for the day.

One may buy Escorts for a target price of Rs 124.50 and keep a stoploss at Rs 115.

Story continues below Advertisement
Remove Ad

One may buy Firstsource Solutions for a target price of Rs 29.60 and keep a stoploss at Rs 27.80.

One may buy Dishman Pharmaceuticals & Chemicals for a target price of Rs 96 and keep a stoploss at Rs 87.50.

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.